Eric Juengst was a featured expert on the potential pitfalls of gene editing in The New York Time’s article “One Day There May Be a Drug to Turbocharge the Brain. Who Should Get It?” by Carl Zimmer.
Eric Juengst was a featured expert on the potential pitfalls of gene editing in The New York Time’s article “One Day There May Be a Drug to Turbocharge the Brain. Who Should Get It?” by Carl Zimmer.